The translation of "3万一针治疗糖尿病" into English is "30,000 RMB for one insulin injection to treat diabetes."

This article discusses the knowledge points related to the treatment of diabetes with a 30,000 yuan per shot. It is hoped that it will be helpful to everyone, and don't forget to bookmark this site. The cost of treating diabetes with insulin generally depends on how much insulin is used and which brand is used. There are many types of insulin available on the market, both domestic and foreign. Domestic insulin is generally relatively cheaper, while insulin produced by foreign companies is slightly more expensive. Based on our experience, a person typically uses around 30-40 units (mixed insulin) per day, using foreign-produced insulin as an example, it costs around 10 Chinese yuan. This is just an average estimate.

Hello, the cost of stem cell transplantation surgery for treating diabetes in a hospital is estimated to be around 30,000 RMB if the hospitalization period is around 30 days and the entire treatment process goes smoothly. Additionally, most of the expenses can be covered by medical insurance. As for the monthly treatment cost for diabetes and hypertension, it is difficult to determine as it depends on factors such as the severity of high blood pressure and blood sugar levels, as well as the presence of complications. The treatment expenses can vary greatly depending on whether domestically produced or imported medications are used, as there is a significant price difference. Personally, I believe the cost of medication is not as important as effectively controlling blood pressure and blood sugar levels, without excessively pursuing expensive medications.

Is insulin covered by medical insurance? How much does it cost after medical insurance coverage? Let me explain below. 1. Is insulin covered by medical insurance? Whether insulin is covered by medical insurance depends on the actual situation. Insulin is usually used to treat diabetes. If it is purchased at a hospital, it is generally covered by medical insurance. However, if it is purchased at an outside pharmacy, it cannot be reimbursed by medical insurance as it is considered a consumable. However, it's worth mentioning that some insurance contracts specifically state that medical expenses related to consumables can be reimbursed. Therefore, whether it is purchased at a hospital or outside, it can be reimbursed. Individuals can purchase insurance policies based on local rules and their own circumstances, which usually cost only a few tens of yuan per year.

According to reports, the centralized procurement of insulin resulted in selected products in November last year. The first-year procurement demand for this centralized procurement was 210 million units, involving an amount of 17 billion yuan. The average price reduction of selected products was 48%, with the highest reduction of 73%. It is estimated that after the centralized procurement, the annual cost of insulin can be reduced by about 9 billion yuan, further reducing the medication burden for over 10 million patients who require long-term or lifelong insulin injections.

The selected insulin products in the centralized procurement are paid based on the selected online price, and the medical insurance fund pays according to a determined proportion. Non-selected insulin products that fall within the scope of medical insurance fund payment will not exceed the highest selected price or negotiated medical insurance price for the same category. For patients using non-selected products, the portion of the price exceeding the medical insurance payment standard is paid by the patients themselves. Each region should balance the online price, patient self-payment ratio, and medical insurance payment standard, and strive to reduce the financial burden on patients.

Insulin is a commonly used medicine for treating diabetes. Since May of this year, China has been implementing centralized procurement of insulin with a volume-based approach, resulting in an average price reduction of 48%. On December 3, 2021, the Chinese Medical Insurance Bureau issued a notice regarding the "Drug Catalog for Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2021)".

If you still want to learn more about this aspect, remember to bookmark and follow this website.